14/05/2026
https://www.facebook.com/share/18xzHCxNvK/
🚨 Landmark Peer-Reviewed Study Identifies Routine Childhood Vaccination as a Significant Modifiable Risk Factor for Autism Spectrum Disorder
Autism Spectrum Disorder now affects more than one in 31 American children.
This represents a sharp and continuing rise that has created profound concern among families and researchers seeking clear answers.
For years, open discussion about possible environmental and medical triggers has faced heavy restrictions.
A major new review published on May 13, 2026, in the Journal of Independent Medicine now brings forward important evidence that could help reopen honest scientific inquiry.
Titled “Determinants of Autism Spectrum Disorder,” this 50-page analysis draws on more than 300 studies across epidemiology, clinical data, toxicology, neuropathology, and mechanistic research.
The authors include Nicolas Hulscher, MPH, Dr. Andrew Wakefield, Dr. Peter A. McCullough, and colleagues from the McCullough Foundation.
The researchers examined many risk factors together in one comprehensive framework.
They found that of 136 studies looking at childhood vaccines or their ingredients, 107 studies (79 percent) reported evidence consistent with a potential link to autism spectrum disorder or related neurodevelopmental problems.
Twelve independent studies compared fully vaccinated children with those who received no vaccines at all.
These consistently showed better overall health in the unvaccinated groups, including substantially lower rates of autism and other chronic conditions.
The paper places vaccination alongside other known influences such as advanced parental age, premature birth, genetic predispositions, maternal immune activation, environmental toxins, and gut-brain axis disruptions.
These factors may interact through immune dysregulation, mitochondrial dysfunction, and neuroinflammation, raising the risk of injury in vulnerable children.
However, the analysis clearly highlights combination and early-timed routine childhood vaccination as one of the most important modifiable risk factors.
This is due to the clustering of multiple doses during critical windows of brain development and the complete lack of long-term safety studies on the full cumulative pediatric vaccine schedule.
In their conclusion, the authors state:
“Combination and early-timed routine childhood vaccination represents a significant modifiable risk factor for ASD within a broader multifactorial framework… As ASD prevalence continues to rise at an unprecedented pace, clarifying the risks associated with cumulative vaccine dosing and timing remains an urgent public health priority.”
This review does not claim vaccines are the only cause.
It shows they may elevate risk in children who already have other vulnerabilities.
Many earlier studies that reported no link had serious limitations, such as lacking true unvaccinated control groups or using methods that could hide effects in more sensitive children.
At the same time, the steady expansion of the childhood vaccine schedule has closely tracked the documented surge in autism rates across birth cohorts.
This peer-reviewed publication marks a notable step in a long-controversial field.
It strengthens the urgent call for independent, large-scale research to provide clearer answers.
Parents and health authorities need the most complete evidence available when making decisions that affect children’s lifelong health.
